“After anecdotal reports of marijuana’s providing antiemetic activity in cancer chemotherapy patients refractory to standard agents, orally administereddelta 9-tetrahydrocannabinol (THC) was formally studied by a number of investigators.
In six of seven well-controlled studies, orally administered THC was a superior antiemetic agent compared with control agents.
Overall, the benefits of orally administered THC use represent a major advance in antiemetic therapy.”